Peer Review History: Survey of Nivolumab and Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma

Editor(s):

(1) Dr. Arulselvan Palanisamy, Associate Professor, Muthayammal Centre for Advanced Research (MCAR), Muthayammal College of Arts and Science, Tamil Nadu, India.

Reviewers:

(1) Prashant Saxena, School of Biotechnology, IFTM University, India.

(2) Ibrahim Mohamed Saeed Shnawa, College of Biotechnology, University of Qasim, Hilla University, College Babylon, Iraq.

(3) Pankaj Shankar Kore, Rajarambapu College of Pharmacy, India.

(4) Arun Dhungana, KU, Nepal.

Additional Reviewers:

(1) Zafar Mehmood, India.

Additional Reviewers: (Comments received after deadline)

(1) Bahaa Kenawy Abuel Hussien, Minia University, Egypt.

(2) Davi Félix Martins Junior, Universidade Estadual de Feira de Santana – UEFS, Brazil.

(3) Jitendriya Panigrahi

(4) Shri Alpesh N Patel Postgraduate Institute of Science and Research, Anand Affiliated to Sardar Patel University, India.

(5) Mohd Shihabuddin Ahmad Noorden, Universiti Teknologi Mara, Malaysia.

(6) Pragati Khare, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.25/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Prashant Saxena, India) | File 1 | NA


Stage 2 | Peer review report_2 (Ibrahim Mohamed Saeed Shnawa, Iraq) | File 1 | NA


Stage 2 | Peer review report_3 (Pankaj Shankar Kore, India) | File 1 | NA


Stage 2 | Peer review report_4 (Arun Dhungana, Nepal) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Posted in Review History.